KH

Kaitou Hanrun Capital

Description

Kaitou Hanrun Capital is an Investment firm.

Investor Profile

Kaitou Hanrun Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kaitou Hanrun Capital frequently co-invest with?

Boquan Capital
Asia, Shanghai, China, Hongkou
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
PS
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
FTZ Fund
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Oriental Fortune Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Kaitou Hanrun Capital?

Ark Biosciences

Shanghai, Shanghai, China

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CJan 22, 2021
Amount Raised: $86,000

Find More Investors Like Kaitou Hanrun Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Kaitou Hanrun Capital | Pipeseed